Bright Peak Therapeutics Announces $107 Million Series B Financing and Expanded Board of Directors
–Proceeds to advance company’s pipeline of next-generation cytokine immunotherapies– –Laura Shawver, Christine Siu join as independent directors– BASEL, Switzerland and